Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in Spain- A Cost-Effectiveness Analysis
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1884
https://www.valueinhealthjournal.com/article/S1098-3015(16)33250-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1778
First Page :
A674
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33250-8&doi=10.1016/j.jval.2016.09.1884